Larkin PR worked with British med-tech company TestCard to raise its profile and promote the roll out of its innovative technology ClearScreen.
ClearScreen is a revolutionary testing app that turns a mobile phone into a clinical grade scanner and could help NHS trusts “save money, time and lives.” It was piloted on dual Covid and Flu testing at Guy’s and St Thomas’ NHS Trust following a successful pilot.
We highlighted the cost and time-saving benefits of its technology which allows faster testing and results without the need of sending tests to the laboratory.
Larkin secured an exclusive profile in the Financial Times with their Global Health Editor Sarah Neville and coverage in a range of trade healthcare and med-tech titles.
